Benefitfocus (BNFT) Outlines 10-Year Vision
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/22/2026
- S&P 500, Dow tick higher as investors weigh Mideast negotiations
- Oil falls 4% after US-Iran talks signal easing supply risks
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Alan Greenspan, influential former Federal Reserve chair, dies at 100
- Buy gold stocks as valuations are cheap amid macro tension: BofA
- CoreWeave trains DeepSeek-V3 in two minutes in MLPerf benchmark
- Needham Starts NeoVolta (NEOV) at Buy
- Companies to add 40 million barrels of oil to US SPR after Iran war ends, energy secretary says
- China makes small dent in deflation battle as supply-demand imbalance persists
- Sanuwave cuts Q2 2026 revenue guidance amid Ultramist sales pressure
Chardan Capital Markets Reiterates Buy on Benefitfocus (BNFT) Following Analyst Day
March 15, 2017 7:18 AM EDTChardan Capital Markets reiterated a Buy rating and $31.00 price target on Benefitfocus (NASDAQ: BNFT) following analyst day.
Analyst Steven Wardell commented, "We maintain our Buy rating on BNFT after attending their annual Analyst Day, at which product launches and a discussion of healthcare... More
